0001246360-12-004853.txt : 20121213
0001246360-12-004853.hdr.sgml : 20121213
20121213170012
ACCESSION NUMBER: 0001246360-12-004853
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20121211
FILED AS OF DATE: 20121213
DATE AS OF CHANGE: 20121213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: IPPOLITO VINCENT P
CENTRAL INDEX KEY: 0001430426
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14471
FILM NUMBER: 121262679
MAIL ADDRESS:
STREET 1: 8125 NORTH HAYDEN ROAD
CITY: SCOTTSDALE
STATE: AZ
ZIP: 85258-2463
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEDICIS PHARMACEUTICAL CORP
CENTRAL INDEX KEY: 0000859368
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 521574808
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7720 DOBSON ROAD
CITY: SCOTTSDALE
STATE: AZ
ZIP: 85256
BUSINESS PHONE: 2125992000
MAIL ADDRESS:
STREET 1: 7720 DOBSON ROAD
CITY: SCOTTSDALE
STATE: AZ
ZIP: 85256
4
1
form.xml
PRIMARY DOCUMENT
X0306
4
2012-12-11
true
0000859368
MEDICIS PHARMACEUTICAL CORP
MRX
0001430426
IPPOLITO VINCENT P
7720 N. DOBSON RD.
SCOTTSDALE
AZ
85256
false
true
false
false
EVP, Sales & Marketing
Common Stock
2012-12-11
4
D
false
187590
44
D
0
D
Employee Stock Option
38.45
2012-12-11
4
D
false
36000
5.55
D
2014-07-16
Common Stock
36000
0
D
On December 11, 2012, the Issuer completed its merger (the "Merger") with Valeant Pharmaceuticals International ("Valeant"), whereby the Issuer became a wholly owned subsidiary of Valeant, pursuant to an Agreement and Plan of Merger that was entered into on September 2, 2012 (the "Merger Agreement"). In accordance with the Merger Agreement, each share of common stock of the Issuer issued and outstanding immediately prior to the consummation of the Merger converted into a right to receive an amount in cash equal to $44.00 per share (the "Per Share Merger Consideration"), without interest. The amount of shares in Column 4 includes 164,205 restricted shares of common stock that also converted into a right to receive the Per Share Merger Consideration.
In accordance with the terms of the Merger Agreement, each option to acquire shares of the Issuer (whether vested or unvested) that was outstanding immediately prior to the consummation of the Merger was cancelled in exchange for the right to receive an amount in cash equal to the product of the number of shares of Issuer common stock subject to the option and the excess, if any, of the Per Share Merger Consideration over the exercise price per share of each respective award, less any required withholding taxes. This award had fully vested prior to the consummation of the Merger.
Vincent P. Ippolito
2012-12-13